2018 | | Cell therapeutic agent for the treating cancer and combination therapy using same | 김성수, 박진성, 서해영, 이영돈, 장다영, 정진화 |
2011 | | COMPOSITION FOR TREATING A CANCER COMPRISINGMESENCHYMAL STEM CELLS ENGINEERED TO EXPRESS SUICIDALGENE | 김성수, 서해영, 유승완, 이영돈, 장다영 |
2016 | | Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas | 김성수, 서해영, 장다영 |
2017 | | Effects of Adenoviral Gene Transduction on the Stemness of Human Bone Marrow Mesenchymal Stem Cells | 김성수, 서해영, 장다영 |
2013 | | Immune following suppression mesenchymal stem cell transplantation in the ischemic brain is mediated by TGF-β. | 김성수, 박진성, 서해영, 이영돈, 장다영, 조은혜 |
2013 | | Retrovirus-mediated transduction of a cytosine deaminase gene preserves the stemness of mesenchymal stem cells. | 김성수, 김세혁, 박준성, 서해영, 이영돈, 장다영 |
2010 | | The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase. | 김성수, 김세중, 서해영, 유승완, 이영돈, 장다영, 조경기 |
2014 | | Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis. | 김성수, 김욱환, 서해영, 이재호, 장다영 |
2015 | | Three-dimensional assessment of bystander effects of mesenchymal stem cells carrying a cytosine deaminase gene on glioma cells. | 김성수, 서해영, 장다영 |